Maria C. Katapodi, Ph.D., RN, FAAN


Adjunct Associate Professor

University of Michigan School of Nursing
400 North Ingalls Building
Ann Arbor, MI 48109-5482

Maria Katapodi is accepting new PhD students.

In the news

Interests

  • Public health genomics – cascade screening
  • Hereditary cancer syndromes
  • Cancer prevention and control
  • Biobehavioral interventions
  • Breast cancer prediction and prognosis models

Her scholarship is in alignment with personalized healthcare and public health genomic interventions. Her program of research contributes to cancer prevention and control through public health and family-based interventions designed to improve awareness of hereditary cancer risk, use of cancer genetic services, and family coping and communication. She pioneered the role of nursing in the development of interventions that enhance cancer risk management in high-risk families at the community level, and brought nursing to the forefront of statewide intervention dissemination.

Current Research Grants and Programs

  • Jan 2018 – Dec 2020 “The CASCADE cohort: A family-based cohort for investigating the use and impact of genetic testing and the development of comprehensive interventions for hereditary breast/ovarian cancer and Lynch syndromes in Switzerland” Swiss Cancer League – KLS-4294-08-2017 PI: Katapodi, MC. Chappuis, PO; Erlanger, TE; Pagani, O; Rabaglio, M; Viassolo, V. and the CASCADE Consortium Co-Investigators. 356’300CHF This family-based cohort surveys HBOC and LS mutation carriers identified from clinic-based records and their blood relatives to determine their cancer status, cancer surveillance practices, quality of life, estimate relative risks associated with behavioral and psychosocial modifiable risk factors, and willingness to participate in a family-based cohort.
  • Jan 2019 – Dec 2022 "SomPsyNet - Prävention psychosozialer Belastungsfolgen in der Somatik: ein Modellprojekt zur kollaborativen Versorgung“ Gesundheitsförderung Schweiz – Healthcare Promotion Network, Katapodi, MC Co-Investigator. 2’101’168 CHF Das Gesundheitsdepartement Basel-Stadt und das Universitätsspital Basel setzen in den kommenden vier Jahren das Projekt gemeinsam mit dem Bethesda-, dem Clara- und dem Felix Platter-Spital sowie wichtigen weiteren Gesundheitsversorgungs-Institutionen um.
  • Jul 2019 – Jun 2021 “Are we offering BRCA1/BRCA2 testing to the right women in Switzerland? Cost-effectiveness of the BRCA mutation testing threshold” Swiss Cancer League - HSR-4671-11-2018 PI: Dedes, KJ. Chappuis, P.O., Katapodi, M.C., Lupatsch, J., Schwenkglenks, M., Thürlimann, B., Unger, S. Co-Investigators. 172’000 CHF The study will assess the current testing practice in Switzerland, cost-effectiveness of HBOC testing and compare it with other possible testing thresholds, and estimate impact on healthcare spending differences if other testing thresholds were chosen.

Teaching

1. Medical and Nursign Care in the Genomics Era. Core course for Master’s nursing students addressing the core genetic/genomic competencies of nurses with advanced practice degrees

2. Intervention development, evaluation, and implementation. Core course for graduate level nursing education.

Affiliations / Service

  • Member, American Academy of Nursing, Genetic Expert Panel, 2012-present (Chairperson 2014-2015)

Notable Awards / Honors

  • Friends of the National Institute of Nursing Research, 1st Protégé Award, 2013
  • Fellow of the American Academy of Nursing, 2012
  • Oncology Nursing Society Excellence in Writing Award for Quantitative Nursing Research, 2010
  • Elizabeth Crosby Research Award, ADVANCE Program, University of Michigan, 2008
  • University of California San Francisco, Graduate Division Research Award, 2003
  • University of California Regents Fellowship, 2001 - 2002

Education

  • Ph.D., University of California San Francisco, San Francisco, CA 2004
  • MSc, University of California San Francisco, San Francisco, CA 2000
  • BSN, National and Kapodistrian University, Athens, Greece 1998

Publication Highlights

  • *Kershaw, T, Ellis, KR, Yoon, H, Schafenacker, A, Katapodi, MC, Northouse, LL (2015) “The interdependence of advanced cancer patients’ and their family caregivers’ mental health, physical health, and self-efficacy over time.” Ann Behav Med, 49(6); 901-911.DOI: 10.1007/s12160-015-9743-y

  • Williams, J.K. Katapodi, M.C., Starkweather, A., Badzek, L.,Cashion, A.,Coleman, B.,Fu, M.,Lyon, D.,Weaver, M.,Hickey, K., (2015). “Nursing engagement in genomic health for all individuals.” Nurs Outlook, 64(2); 117-123, doi: 10.1016/j.outlook.2015.11.009.

  • *Weiss, D, Northouse, LL, Katapodi, MC, Ingersoll-Dayton, B, Duffy, S. (2016) “Qualitative analysis of the experience of mental fatigue of family caregivers of cancer patients participating in phase I clinical trials.” Onc Nurs Forum, 43(4):E153-160, doi: 10.1188/16.ONF.E153-E160.

  • *Freeman-Gibb, LA, Janz, NK, Katapodi, MC, Zikmund-Fisher, BJ, Northouse, LL (2017). “The relationship between illness representations, risk perception and fear of cancer recurrence in breast cancer survivors.” Psychooncology, 26(9):1270-1277. doi: 10.1002/pon.4143.

  • *Jones, T, Lockhart, JS, Mendelsohn-Victor, KE, Duquette, D, Northouse, LL, Duffy, SM, Donley, R, Merajver, SD, Milliron, KJ, Roberts, JS, Katapodi, MC. (2016). “Use of cancer genetic services in African American young breast cancer survivors.” Am J Prev Med, 51(4); 427-436, doi: 10.1016/j.amepre.2016.03.016.

  • Hickey, KT, Katapodi, MC, Coleman, B, Reuter-Rice, K, Starkweather, AR. (2017). “Improving Utilization of the Family History in the Electronic Health Records.” J Nurs Scholarsh, 49(1); 80-86, doi:10.1111/jnu.12259.

  • *Katapodi, MC, Duquette, D, Yang, JJ, Mendelsohn-Victor, KE, Anderson, B, Nikolaidis, C, Mancewicz, E. Northouse, LL, Duffy, S, Ronis, D†, Milliron, KJ, Probst-Hensch, N. Merajver, SD, Janz, NK, Copeland, G,Roberts, SJ. (2017). “Recruiting families at risk for hereditary breast and ovarian cancer from a statewide cancer registry: A methodological study.” Cancer Causes Control, 28(3); 191-201, doi:10.1007/s10552-017-0858-2.

  • Katapodi, MC, Viassolo, V, Caiata-Zufferey, M, Nikolaidis, C, Bührer-Landolt, R, Bürki, N, Graffeo, R, Horváth, H, Kurzeder, C, Rabaglio, M, Scharfe, M, Urech, C, Erlanger, TE, Probst-Hensch, N, Heinimann, K, Heinzelman-Schwartz, V, Pagani, O, Chappuis, PO, for the Swiss Cancer Predisposition Cascade Genetic Screening Consortium. ( 2017). “Cancer predisposition cascade screening for hereditary breast/ovarian cancer and Lynch syndromes in Switzerland: Study Protocol.” JMIR –  Res Protoc, 6(9):e184, doi: 10.2196/resprot.8138.

  • *Hickey, K, Taylor, JY, Barr, TL, Hauser, NR, Jia, H, Riga, TC, Katapodi, MC. (2018).“Nursing genetics and genomics: The International Society of Nurses in Genetics (ISONG) survey.” Nurse Educ Today, 12;63:12-17, doi: 10.1016/j.nedt.2018.01.002.

  • *Jones, T, Duquette, D, Underhill,M, Ming, C, Mendelsohn-Victor, KE, Anderson, B, Milliron, KJ, Copeland, G, Janz, NK, Northouse, LL, Duffy, SA, Merajver, SD, Katapodi, MC. (2018). “Surveillance for cancer recurrence in long-term young breast cancer survivors randomly selected from a statewide cancer registry.“ Breast Cancer Res Treat, 169(1), 141-152, doi: 10.1007/s10549-018-4674-5.

  • *Katapodi, MC, Jung, M., Schafenacker, AM., Milliron, KJ., Mendelsohn-Victor, KE., Merajver, SD., Northouse, LL. (2018). “Development of a family-based intervention for BRCA carriers and their at-risk relatives: Focus groups, usability, and feasibility testing.” JMIR – Cancer, 4(1):e7.doi:10.2196/cancer.9210.

  • *Katapodi, MC, Ellis, K, Schmidt, F, Nikolaidis, C, Northouse, LL. (2018). “Predictors and interdependence of family support in a random sample of long-term young breast cancer survivors and their close biological relatives.” Cancer Med, 7(10):4980-4992, Doi.org/10.1002/cam4.1766.

  • *Nikolaidis, C, Duquette, D, Mendelsohn-Victor, KE, Anderson, B, Copeland, G, Milliron, KJ, Merajver, SD, Janz, NK, Northouse, LL, Duffy, SA, Katapodi, MC. (2019). “Disparities in genetic services utilization in a random sample of young breast cancer survivors.” Genet Med, 21(6):1363-1370, doi: 10.1038/s41436-018-0349-1. [Epub ahead of print]

  • *Nikolaidis, C, Ming, C, Ademi Z, Bührer-Landolt, R, Bürki, N, Caiata-Zufferey M, Champion V, Chappuis PO, Erlanger, TE, Graffeo, R, Hampel H, Heinimann, K, Heinzelmann-Schwarz, V, Kurzeder, C, Monnerat, C, Northouse, LL, Pagani, O, Probst-Hensch, N, Rabaglio, M, Schoenau, E, Sijbrands, E, Taborelli, M, Viassolo, V, Wieser, S, Katapodi, MC, for the CASCADE Consortium. (2019). “Challenges and Opportunities for Cancer Predisposition Cascade Screening for Hereditary Breast and Ovarian Cancer and Lynch Syndrome in Switzerland: Findings from an International Workshop.” Public Health Genomics, 21(3-4):121-132. doi: 10.1159/000496495.

  • *Ming, C, Viassolo, V, Probst-Hensch, N, Chappuis, PO, Dinov, ID, Katapodi, MC. (2019). “Machine learning techniques for personalized breast cancer risk prediction: comparison with the BCRAT and BOADICEA models.” Breast Cancer Res, 21(1):75. doi: 10.1186/s13058-019-1158-4

Download CV